Purac Bioquimica Sau, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is L(+)LACTIC ACID, with a corresponding US DMF Number 20726.
Remarkably, this DMF maintains an Active status since its submission on July 26, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 28, 2022, and payment made on September 23, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II